Du YY - Search Results

1

Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer.

Zhao CC, Zhan MN, Liu WT, Jiao Y, Zhang YY, Lei Y, Zhang TT, Zhang CJ, Du YY, Gu KS, Wei W. Zhao CC, et al. Among authors: du yy. Cancer Lett. 2020 Nov 28;493:120-127. doi: 10.1016/j.canlet.2020.08.006. Epub 2020 Aug 21. Cancer Lett. 2020. PMID: 32829006

2

Intravenous flurbiprofen axetil can increase analgesic effect in refractory cancer pain.

Wu H, Chen Z, Sun G, Gu K, Pan Y, Hao J, Du Y, Ning J. Wu H, et al. J Exp Clin Cancer Res. 2009 Mar 7;28(1):33. doi: 10.1186/1756-9966-28-33. J Exp Clin Cancer Res. 2009. PMID: 19267934 Free PMC article.

3

The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway.

Lei Y, Li HX, Jin WS, Peng WR, Zhang CJ, Bu LJ, Du YY, Ma T, Sun GP. Lei Y, et al. Among authors: du yy. Int J Radiat Biol. 2013 Dec;89(12):1079-86. doi: 10.3109/09553002.2013.825058. Epub 2013 Oct 25. Int J Radiat Biol. 2013. PMID: 23875954

4

Synergistic effects of combined treatment with simvastatin and exemestane on MCF-7 human breast cancer cells.

Shen Y, Du Y, Zhang Y, Pan Y. Shen Y, et al. Mol Med Rep. 2015 Jul;12(1):456-62. doi: 10.3892/mmr.2015.3406. Epub 2015 Mar 3. Mol Med Rep. 2015. PMID: 25738757

5

Serum expression and significance of MicroRNA-30d-5p in esophageal squamous cell carcinoma.

Zhu Y, Liu J, Fan L, Wang F, Bu L, Ma T, Du Y, Zhang C, Wang H, Sun G. Zhu Y, et al. Int J Clin Exp Pathol. 2017 Aug 1;10(8):8677-8685. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966725 Free PMC article.

6

Effective treatment of advanced lung adenocarcinoma with paraneoplastic leukemoid reaction with Lorlatinib: a case report.

Niu R, Zhang Y, Pang J, Zhou Q, Lei Y, Du Y. Niu R, et al. Front Oncol. 2024 Jan 26;14:1341233. doi: 10.3389/fonc.2024.1341233. eCollection 2024. Front Oncol. 2024. PMID: 38344203 Free PMC article.

7

Synergistic effects of exemestane and aspirin on MCF-7 human breast cancer cells.

Hu LX, Du YY, Zhang Y, Pan YY. Hu LX, et al. Among authors: du yy. Asian Pac J Cancer Prev. 2012;13(11):5903-8. doi: 10.7314/apjcp.2012.13.11.5903. Asian Pac J Cancer Prev. 2012. PMID: 23317278 Free article.

8

Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells.

Shen YY, Yuan Y, Du YY, Pan YY. Shen YY, et al. Among authors: du yy. Mol Med Rep. 2015 Jul;12(1):623-30. doi: 10.3892/mmr.2015.3411. Epub 2015 Mar 4. Mol Med Rep. 2015. PMID: 25738368

9

Study of efficacy and safety of pulsatile administration of high-dose gefitinib or erlotinib for advanced non-small cell lung cancer patients with secondary drug resistance: A single center, single arm, phase II clinical trial.

Zhu Y, Du Y, Liu H, Ma T, Shen Y, Pan Y. Zhu Y, et al. Thorac Cancer. 2016 Nov;7(6):663-669. doi: 10.1111/1759-7714.12384. Epub 2016 Aug 24. Thorac Cancer. 2016. PMID: 27755796 Free PMC article. Clinical Trial.

10

Secreted Heat Shock Protein 90α Attenuated the Effect of Anticancer Drugs in Small-Cell Lung Cancer Cells Through AKT/GSK3β/β-Catenin Signaling.

Du Y, Wu J, Luo L. Du Y, et al. Cancer Control. 2018 Jan-Dec;25(1):1073274818804489. doi: 10.1177/1073274818804489. Cancer Control. 2018. PMID: 30282477 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters